Loading...
XHKG
3613
Market cap977mUSD
Jul 15, Last price  
9.17HKD
1D
-0.65%
1Q
8.91%
Jan 2017
-12.50%
IPO
15.35%
Name

Beijing Tong Ren Tang Chinese Medicine Co Ltd

Chart & Performance

D1W1MN
P/E
15.34
P/S
4.76
EPS
0.60
Div Yield, %
7.20%
Shrs. gr., 5y
Rev. gr., 5y
2.38%
Revenues
1.61b
+5.69%
333,039,000613,963,000761,051,000970,477,0001,084,280,0001,265,994,0001,513,873,0001,432,632,0001,315,346,0001,556,158,0001,731,095,0001,524,945,0001,611,644,000
Net income
500m
-7.42%
155,935,000220,001,000287,124,000354,249,000420,315,000489,967,000580,720,000556,118,000542,456,000607,838,000645,875,000540,393,000500,278,000
CFO
0k
-100.00%
185,096,000142,528,000244,734,000353,576,000467,721,000469,144,000577,684,000551,010,000116,054,000777,170,000547,444,000460,831,0000
Dividend
Jun 12, 20240.33 HKD/sh

Profile

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
IPO date
May 07, 2013
Employees
789
Domiciled in
HK
Incorporated in
HK

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,611,644
5.69%
1,524,945
-11.91%
1,731,095
11.24%
Cost of revenue
1,047,439
900,200
930,335
Unusual Expense (Income)
NOPBT
564,205
624,745
800,760
NOPBT Margin
35.01%
40.97%
46.26%
Operating Taxes
100,606
97,203
134,669
Tax Rate
17.83%
15.56%
16.82%
NOPAT
463,599
527,542
666,091
Net income
500,278
-7.42%
540,393
-16.33%
645,875
6.26%
Dividends
(276,243)
(443,663)
Dividend yield
2.71%
4.62%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
57,479
56,420
42,348
Long-term debt
189,148
206,874
163,264
Deferred revenue
333
Other long-term liabilities
11,796
(333)
Net debt
(1,648,521)
(2,175,200)
(1,847,968)
Cash flow
Cash from operating activities
460,831
547,444
CAPEX
(21,866)
(38,509)
Cash from investing activities
(1,078,521)
335,412
Cash from financing activities
(372,181)
(535,416)
FCF
(246,625)
338,464
451,332
Balance
Cash
1,832,959
2,378,693
2,243,963
Long term investments
62,189
59,801
(190,383)
Excess cash
1,814,566
2,362,247
1,967,025
Stockholders' equity
4,246,434
4,070,108
3,779,859
Invested Capital
2,567,084
1,790,256
1,734,039
ROIC
21.28%
29.94%
35.77%
ROCE
12.88%
15.01%
21.59%
EV
Common stock shares outstanding
837,100
837,100
837,100
Price
8.78
-27.80%
12.16
6.11%
11.46
-14.61%
Market cap
7,349,738
-27.80%
10,179,136
6.11%
9,593,166
-14.61%
EV
5,872,291
8,158,113
7,907,447
EBITDA
564,205
707,259
876,230
EV/EBITDA
10.41
11.53
9.02
Interest
5,978
4,661
Interest/NOPBT
0.96%
0.58%